Series A funding round for ReNAgade Therapeutics raising $300M in May 2023
Series A funding round for ReNAgade Therapeutics raising $300M in May 2023
| Investor | Firm Type | Partner |
|---|
F2 VenturesLEAD | Venture Capital | — |
MPM CapitalLEAD | Venture Capital | — |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$300M
Top Valuation
-
ReNAgade Therapeutics raised $300M in a Series A round.
The round was announced on 05/01/23.
The round was led by MPM Capital, F2 Ventures.